Improved Cardiovascular & Metabolic Health Studies show GLP-1 medications may improve cholesterol levels, blood pressure, insulin sensitivity, and other markers associated with metabolic syndrome and cardiovascular disease
They can help you navigate any challenges and optimize your overall health
The demographic and clinical characteristics of patients including age, sex, MELD score, cold ischemia time, race/ethnicity, etiology of ALF, and length of stay, who were listed after a weekend compared to other days, were comparable
Triple agonists targeting GLP-1, GIP, and glucagon are in development, requiring devices that can handle their specific formulations
Most leaders are not overwhelmed because they lack skill or commitment
doi:.10.1002/14651858.CD003990.pub4 [PMC free article: PMC6485821] [PubMed: 23543528] [CrossRef] 266